Scientific Signal Intelligence

See who's about to
buy — before
they know it.

Biointelli Predict™

Every grant awarded, paper published, patent filed, and conference attended is a buying signal hiding in plain sight. We find them first — and turn them into your pipeline.

BIOINTELLI PREDICT™ — LIVE SIGNALS LIVE
4,312
New Grants / Wk
12,891
Publications / Wk
847
Conf. Signals / Wk
Recent Scientific Signals View All →
Dr. Emily Carter
Dana-Farber Cancer Inst.
NIH Grant
$2.3M
Apr 14
Dr. Raj Patel
Stanford University
Publication
Apr 13
Dr. Lisa Nguyen
UCSF
Conference
AACR
Apr 12
Dr. Michael Lee
MD Anderson
NIH Grant
$1.8M
Apr 12
Dr. Sarah Johnson
Harvard Medical School
Publication
Apr 11
NIH Awards This Week↑ 4,312 · New Publications↑ 12,891 · Biotech Companies Signaling2,471 · Funding Tracked This Month$4.7B+ · Research Institutions1,982 · Conference Signals↑ 847 · Signals Processed Weekly100K+ · NSF Awards This Week↑ 892 · NIH Awards This Week↑ 4,312 · New Publications↑ 12,891 · Biotech Companies Signaling2,471 · Funding Tracked This Month$4.7B+ · Research Institutions1,982 · Conference Signals↑ 847 · Signals Processed Weekly100K+ · NSF Awards This Week↑ 892
Trusted by Life Science Innovators
ThermoFisher
Danaher
Illumina
Merck
Regeneron
Bristol Myers Squibb
2,471
Biotech companies
actively signaling demand
$4.7B+
In new research funding
tracked this month
100K+
Signals processed
every week
18yr
Building the world's deepest
life science signal database
A New Category

What is Scientific
Signal Intelligence?

The life science market doesn't announce intent. Researchers don't fill out RFPs before they need reagents, instruments, or services. But they leave signals — everywhere.

Scientific Signal Intelligence (SSI) is the systematic collection, enrichment, and interpretation of public scientific activity to predict commercial demand — before it surfaces in any CRM.

USPTO Provisional Patent No. 63/998,284
The SSI methodology aggregates signals from government funding databases, publication archives, patent filings, conference registrations, and hiring patterns — and transforms them into a ranked, actionable intelligence layer for life science commercial teams.
💰
Grant & Funding Signals
NIH, NSF, EU Horizon Europe, DoD, and 40+ global funding bodies. Know who just got funded and what they'll need next.
📄
Publication Velocity
Track publication rate, citation momentum, and research focus shifts across 70M+ papers. Active publishing = active purchasing.
🎯
Conference Presence
AACR, ASHP, ASH, SfN and 3,200+ conferences mapped. Attendance and presentation signals indicate active research phases.
Clinical & Patent Activity
Trial initiations, IND filings, patent applications. Regulatory momentum is the strongest commercial signal of all.
The Platform

From raw signal to
closed deal

Four steps. Fully automated. Updated daily.

Step 01
📡
Collect
Real-time ingestion from 60+ global sources — government grant APIs, publication databases, patent offices, conference registrations, hiring boards.
Step 02
🔬
Enrich
Every signal is matched to a researcher, lab, or institution — enriched with verified contact data, organizational hierarchy, and purchase history context.
Step 03
🧠
Score
The BioSuccess Score™ ranks accounts by commercial momentum — integrating signal density, funding trajectory, publication velocity, and buying pattern modeling.
Step 04
🚀
Act
Prioritized account lists, verified contacts, and signal-triggered alerts delivered to your CRM — Salesforce, HubSpot, Veeva — so your team engages at the right moment.
The Advantage

Why Biointelli
wins

🏛️
18 Years of Signal History
Our database goes back to 2007. Pattern recognition across two decades of scientific activity means our models see what others simply can't — because they haven't been watching long enough.
🌍
Global Coverage, Not Just US
NIH and NSF are just the start. We cover EU Horizon Europe, UKRI, DFG, Swiss NSF, and 40+ additional funding bodies. Your global accounts are fully mapped.
⚖️
The Only Registered SSI Provider
Biointelli is the only Scientific Signal Intelligence provider registered under California's data broker framework — providing compliance assurance that foreign-domiciled competitors cannot match.
🔌
REST API + CRM Native
Full Swagger/OAS 3.0 documented API. Pre-built connectors for Salesforce, HubSpot, and Veeva. SSI data flows directly into the tools your commercial team already uses.
🎯
6–12 Month Early Warning
Grant-to-purchase cycles average 6 to 12 months. We put you in front of accounts before your competitors know they exist — at the exact moment budget decisions are forming.
🔒
Patented Methodology
The SSI scoring and enrichment methodology is protected under USPTO Provisional Patent No. 63/998,284 — a defensible moat built on 18 years of proprietary data architecture.
Competitive Landscape

Not a data vendor.
A signal layer.

Traditional life science data vendors sell lists. Biointelli Predict™ sells intelligence — the difference between knowing who exists and knowing who's ready to buy.

Capability
Biointelli
Others
Real-time signal ingestion
Global funding coverage (40+ sources)
BioSuccess Score™ (predictive ranking)
18-year signal history
CA data broker compliant
REST API + CRM connectors
~
01
The Signals Are Public. The Advantage Is Ours.
Grant data, publications, and conference records are all public. The advantage is in aggregating, enriching, and scoring them faster and more completely than anyone else.
02
Built for Commercial Teams, Not Data Scientists
No SQL required. Prioritized account queues, signal alerts, and territory dashboards built for AEs, SDRs, and sales leaders who need answers in seconds.
03
Enterprise-Grade. AACR-Proven.
Live with Thermo Fisher Scientific and Danaher. Launched to the global life science commercial community at AACR 2026 — the industry's definitive signal intelligence platform.
Ready to See What You've Been Missing?

Your competitors are
already signaling.

Every week you wait, 4,300+ new grants are awarded. 12,000+ papers are published. Thousands of buying decisions are forming — without you in the room. Let's change that.